MIRM
Mirum Pharmaceuticals
$114.20
+$1.18 (+1.04%)Jul 27, 2026
Key metrics
The numbers that frame MIRM today
- Market cap
- $6.96B
- P/E (TTM)
- -8.7
- EV / FCF
- -40.3
- Gross margin
- 81.4%
- EV / Sales
- 12.2
- ROIC
- -194.3%
- Div yield
- 0%
- Debt / equity
- 1.3
- 52wk Low
- $50.25
- 52wk High
- $130.00
Growth
Revenue and earnings trend for MIRM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MIRM
Is Mirum Pharmaceuticals a good buy?
Hold. Mirum Pharmaceuticals has excellent momentum, but weak quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Mirum Pharmaceuticals is selling at a high price.
What is the market capitalization of MIRM?
Mirum Pharmaceuticals's market capitalization is $6.96B.
What is the P/E ratio for MIRM stock?
Mirum Pharmaceuticals's current P/E ratio is -8.7.
What is the 52-week high for MIRM stock?
The 52-week high for Mirum Pharmaceuticals is $130.00. The current close of $114.20 is 12.2% below that high.
What is the 52-week low for MIRM stock?
The 52-week low for Mirum Pharmaceuticals is $50.25. The current close of $114.20 is 127.3% above that low.
Does MIRM stock pay dividends?
Mirum Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for MIRM?
Mirum Pharmaceuticals's Debt / Equity ratio is 1.33.